Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
712
7
Mar 27, 2025
$101,431
38
2023
0
| Associate Director, Patient & Provider Analytics | FY 2026 Q2 | $169,541/yr | Mar 24 '26Mar 24, 2026 |
| AD, Patient and Provider Analytics - CRM | FY 2026 Q2 | $169,541/yr | Mar 24 '26Mar 24, 2026 |
| Clinical Trial Leader I | FY 2026 Q2 | $141,398/yr | Mar 24 '26Mar 24, 2026 |
| Principal Biostatistician | FY 2026 Q2 | $112,965/yr | Mar 24 '26Mar 24, 2026 |
| Expert CMC Statistics | FY 2026 Q2 | $112,965/yr | Mar 24 '26Mar 24, 2026 |
| Senior Principal Statistician | FY 2026 Q2 | $112,965/yr | Mar 24 '26Mar 24, 2026 |
| Finance Manager | FY 2026 Q2 | $73,195/yr | Mar 24 '26Mar 24, 2026 |
| Associate Clinical Development Medical Director | FY 2026 Q2 | $116,730/yr | Mar 23 '26Mar 23, 2026 |
| Principal Biostatistician | FY 2026 Q2 | $112,965/yr | Mar 23 '26Mar 23, 2026 |
| AD, Integrated Field Execution Effectiveness - CE | FY 2026 Q2 | $169,541/yr | Mar 20 '26Mar 20, 2026 |
| Associate Director, PSC Operations Insights | FY 2026 Q2 | $169,541/yr | Mar 20 '26Mar 20, 2026 |
| Director, Product Strategy Counsel | FY 2026 Q2 | $156,832/yr | Mar 20 '26Mar 20, 2026 |
| Study Leader | FY 2026 Q2 | $141,398/yr | Mar 20 '26Mar 20, 2026 |
| Principal Biostatistician | FY 2026 Q2 | $112,965/yr | Mar 20 '26Mar 20, 2026 |
| Principal Biostatistician | FY 2026 Q2 | $112,965/yr | Mar 20 '26Mar 20, 2026 |
| Principal Biostatistician | FY 2026 Q2 | $112,965/yr | Mar 20 '26Mar 20, 2026 |
| Director, Forecasting-CV | FY 2026 Q2 | $169,541/yr | Mar 19 '26Mar 19, 2026 |
| Principal Biostatistician | FY 2026 Q2 | $112,965/yr | Mar 19 '26Mar 19, 2026 |
| Expert Science & Technology | FY 2026 Q2 | $96,054/yr | Mar 19 '26Mar 19, 2026 |
| Principal Biostatistician | FY 2026 Q2 | $89,731/yr | Mar 19 '26Mar 19, 2026 |
| Associate Expert Potency | FY 2026 Q2 | $89,419/yr | Mar 19 '26Mar 19, 2026 |
| Director, Emerging Data Products - NS | FY 2026 Q2 | $223,642/yr | Mar 18 '26Mar 18, 2026 |
| Head of Strategy, US | FY 2026 Q2 | $223,142/yr | Mar 18 '26Mar 18, 2026 |
| Associate Director, Business Performance - CRM | FY 2026 Q2 | $169,541/yr | Mar 18 '26Mar 18, 2026 |
| Operational Health Project Manager | FY 2026 Q2 | $129,709/yr | Mar 18 '26Mar 18, 2026 |
| FDP Associate | FY 2026 Q2 | $112,778/yr | Mar 18 '26Mar 18, 2026 |
| Technology Product Director | FY 2026 Q2 | $223,642/yr | Mar 10 '26Mar 10, 2026 |
| Director, Integrated Field Targeting and NBA - CE | FY 2026 Q2 | $169,541/yr | Mar 9 '26Mar 9, 2026 |
| Senior Product Manager - Novartis Patient Support | FY 2026 Q2 | $126,818/yr | Feb 20 '26Feb 20, 2026 |
| Associate Director, Monitoring and Standards | FY 2026 Q2 | $169,541/yr | Feb 10 '26Feb 10, 2026 |
| Global Regulatory Submission Manager | FY 2026 Q2 | $141,190/yr | Jan 6 '26Jan 6, 2026 |
| Senior Principal Product Service Manager | FY 2026 Q2 | $126,818/yr | Jan 6 '26Jan 6, 2026 |
| Director, Resource Optimization Commercial | FY 2026 Q2 | $223,142/yr | Dec 19 '25Dec 19, 2025 |
| Director, Resource Optimization Commercial | FY 2026 Q2 | $223,142/yr | Dec 10 '25Dec 10, 2025 |
| Director, AI Use Case Lead | FY 2026 Q2 | $185,723/yr | Dec 10 '25Dec 10, 2025 |
| Director - Decision Science, Immunology Product Lead | FY 2026 Q2 | $138,466/yr | Nov 25 '25Nov 25, 2025 |
| Manager, HCP Education Delivery | FY 2026 Q2 | $143,250/yr | Sep 29 '25Sep 29, 2025 |
| Principal Biostatistician | FY 2026 Q2 | $127,858/yr | Sep 29 '25Sep 29, 2025 |
